MétaCan
Menu
← Back to cohort
Record W6923535322 · doi:10.14288/1.0437106

Folic acid supplementation and dietary folate intake in children with sickle cell disease : a double-blind randomized non-inferiority cross-over trial

2025· article· en· W6923535322 on OpenAlexaboutno aff

Bibliographic record

VenuecIRcle (University of British Columbia) · 2025
Typearticle
Languageen
FieldMedicine
TopicHemoglobinopathies and Related Disorders
Canadian institutionsnot available
Fundersnot available
KeywordsDiseaseCellFolic acid supplementationSickle cell anemiaClinical trial

Abstract

fetched live from OpenAlex

Supplementation with 1-5 mg/d folic acid, a synthetic form of folate, is the routine recommendation for Canadian individuals with sickle cell disease (SCD), an inherited hemoglobin disorder thought to increase requirements for folate due to chronic hemolysis and increased folate-dependent erythropoiesis. There is concern about whether children with SCD need such high doses of folic acid following mandatory folic acid fortification of refined grains and advancements in medical therapies for SCD in Canada. Thus, I conducted a double-blind randomized cross-over trial to determine the efficacy of folic acid supplementation by measuring the effect of folic acid, compared to placebo, on the primary outcome of red blood cell (RBC) folate concentrations in children with SCD. Children with SCD (n=31) in British Columbia were randomized to either 1 mg/d folic acid (current standard of care), or a placebo for 12 ± 1 weeks. After a 12 ± 1 week washout period, treatments were reversed. RBC folate concentrations were measured via microbiological assay and serum folate concentrations were measured via LC-MS/MS at baseline and after treatment periods. Mean differences in RBC and serum folate concentrations by treatment were evaluated using generalized linear regression models. Dietary intake was collected and analyzed from non-consecutive 24-hour dietary recalls. Inadequate dietary folate intake, defined as below the Estimated Average Requirement, was observed in 31% (n=8/26) of participants. In intention-to-treat analyses, the adjusted mean difference in RBC folate concentrations across treatments (placebo vs. folic acid) was -248 (95% CI: -367, -129) nmol/L (p<0.001). In per-protocol analyses (excluding periods with >1 RBC transfusion), the mean adjusted difference was -224 (95% CI: -336, -111) nmol/L (p<0.001). As per the ‘a priori’ defined non-inferiority margin of -227 nmol/L, the results were equivocal regarding non-inferiority of placebo in comparison to folic acid for the maintenance of RBC folate concentrations over 12 weeks. There was no significant difference in adjusted mean serum folate concentrations across treatments (-7 [95% CI: -35, 21] nmol/L, p=0.610). Future in vitro work in which the folate capacity of sickled red blood cells is tested could further inform interpretation of folate status in this population with abnormally shaped RBCs.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.002
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0050.002
Bibliometrics0.0010.000
Science and technology studies0.0010.002
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.225
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuecIRcle (University of British Columbia)→Same topicHemoglobinopathies and Related Disorders→French-language works237,207→